IDOFNIB 150MG CAPSULE contains Nintedanib, a tyrosine kinase inhibitor.
Used primarily to manage idiopathic pulmonary fibrosis (IPF) and other progressive fibrosing interstitial lung diseases.
Works by slowing the rate of lung function decline and reducing scarring (fibrosis) in lung tissues.
Has anti-fibrotic and anti-cancer properties and is also indicated alongside chemotherapy for certain types of non-small cell lung cancer (NSCLC) of adenocarcinoma histology.
Should be used exactly as prescribed by a healthcare professional, with routine blood tests often required to monitor for safety and efficacy.
Please complete your information below to login.
Sign In
Create New Account